A New Paradigm Shift: Parts 1 and 2 (Pages 25-31)
DUE TO THE AGING OF THE population, most of our population will spend roughly half of their lives as presby-opes. The etiology of presby-opia has been poorly understood, and treatment options have failed to address the true issues with the disease, creating compro mises in vision that patients are eager to find a solution for, not expecting to have their daily lives affected. There is both an overlooked etiology regarding the mechanism of presbyopia in the medical community, as well as a lack of awareness in the presbyopic population in general. If we are to be successful in implementing presbyopic solutions that address the pathogenesis, onset, and progressive compounding of the clinical manifestations that accompany presbyopia, there must be an effort toward shifting the paradigm of education and awareness toward the real issues that provoke this elusive age-related disease.
Explore More Articles
Ace Vision Group Names Rob Kissling, MD, as Chief Medical Officer
Ace Vision Group announced that it has named Rob Kissling, MD, as Chief Medical Officer. Dr. Kissling has more than 20 years of experience integrating clinical development, medical strategy, and business planning to develop and commercialize devices and medicines for ophthalmology. His tenure has included companies such as Pharmacia, Pfizer, and Novartis. Most recently, he …
read moreLaser scleral microporation treatment may be ‘game changer’ for presbyopia
CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Dagny Zhu, MD, and AnnMarie Hipsley, DPT, PhD, discuss laser scleral microporation for presbyopia. Hipsley said it is important to understand that presbyopia is an aging disease rather than a refractive disorder. Catching it early and treating it can be beneficial for patients. Zhu said laser …
read moreLaser scleral microporation has high satisfaction in emmetropic presbyopes
SAN DIEGO — In this Healio Video Perspective from the ASCRS meeting, Robert Ang, MD, discusses 18-month study outcomes of laser scleral microporation in emmetropic presbyopes. “Our studies show that the patients have high patient satisfaction with laser scleral microporation treatment,” he said. “It is safe and effective, and it has great potential for this segment of …
read more